Q4 2020 Holdings
Filed 2021-02-16 | 69 holdings | $284.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | ADR | 04351P101 | $185.1M | 1,109,874 | 65.0% |
| Abbvie Inc(ABBV) | COMM | 00287Y109 | $31.5M | 293,596 | 11.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COMM | 09061G101 | $14.4M | 164,545 | 5.1% |
| Aclaris Therapeutics(ACRS) | COMM | 00461U105 | $12.4M | 1,911,573 | 4.3% |
| Cytokinetics Inc(CYTK) | COMM | 23282W605 | $10.6M | 508,394 | 3.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COMM | 004225108 | $8.8M | 164,625 | 3.1% |
| BioCryst Pharmaceuticals Inc(BCRX) | COMM | 09058V103 | $8.4M | 1,122,800 | 2.9% |
| Coherus BioSciences(CHRS) | COMM | 19249H103 | $7.6M | 434,555 | 2.7% |
| Arcus Biosciences Inc(RCUS) | COMM | 03969F109 | $4.8M | 186,278 | 1.7% |
| Natera(NTRA) | COMM | 632307104 | $308.6K | 3,100,560 | 0.1% |
| Karuna Therapeutics, Inc. | COMM | 48576A100 | $198.3K | 1,952,441 | 0.1% |
| Y-mAbs Therapeutics, Inc(YMABUSD) | COMM | 984241109 | $108.6K | 2,194,278 | 0.0% |
| United Therapeutics Corp(UTHR) | COMM | 91307C102 | $52.8K | 347,901 | 0.0% |
| Checkmate Pharmaceuticals Inc | COMM | 162818108 | $52.6K | 3,606,707 | 0.0% |
| AstraZeneca PLC(AZN) | ADR | 046353108 | $42.1K | 842,600 | 0.0% |
| Inozyme Pharma, Inc. | COMM | 45790W108 | $41.9K | 2,028,308 | 0.0% |
| Amgen Inc(AMGN) | COMM | 031162100 | $37.9K | 164,663 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | COMM | G50871105 | $35.1K | 212,911 | 0.0% |
| Health Care Select Sector Spdr(XLV)Put | COMM | 81369Y209 | $34.0K | 300,000 | 0.0% |
| Galera Therapeutics, Inc(GRTX) | COMM | 36338D108 | $31.5K | 3,083,712 | 0.0% |
| Akouos, Inc | ADR | 00973J101 | $30.0K | 1,515,074 | 0.0% |
| Nextcure, Inc | COMM | 00653E112 | $29.1K | 2,671,856 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COMM | 46116X101 | $27.0K | 848,162 | 0.0% |
| iShares Russell 2000 ETF(IWM)Put | COMM | 464287655 | $25.5K | 130,000 | 0.0% |
| Nucana Biomed Ltd | ADR | 67022C106 | $25.1K | 5,599,999 | 0.0% |
| Merus N.V. | COMM | N5749R100 | $23.0K | 1,311,039 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COMM | 69366J200 | $19.3K | 316,478 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | COMM | 75615P103 | $18.4K | 148,937 | 0.0% |
| Athira Pharma, Inc. | COMM | 04746L104 | $17.4K | 509,168 | 0.0% |
| Otonomy Inc | COMM | 68906L105 | $17.0K | 2,620,668 | 0.0% |
| Horizon Therapeutics PLC | COMM | G46188101 | $15.6K | 213,390 | 0.0% |
| Protagonist Therapeutics Inc | COMM | 00744E106 | $14.6K | 724,904 | 0.0% |
| Regenxbio Inc(RGNX) | COMM | 75901B107 | $12.3K | 271,114 | 0.0% |
| GW Pharmaceuticals PLC | ADR | 36197T103 | $11.6K | 100,762 | 0.0% |
| Nucana Biomed Ltd | Ordinary Shares | GBOOBYWYV | $10.8K | 2,400,000 | 0.0% |
| MacroGenics Inc(MGNX) | COMM | 556099109 | $10.5K | 458,807 | 0.0% |
| Tcr2 Therapeutics Inc | COMM | 87808K106 | $10.3K | 333,707 | 0.0% |
| Insmed Inc(INSM) | COMM | 457669307 | $10.3K | 309,662 | 0.0% |
| ObsEva SA | COMM | H5861P103 | $9.9K | 4,749,623 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COMM | 040047607 | $9.3K | 121,373 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COMM | 803607100 | $8.8K | 51,848 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COMM | 87164F105 | $8.3K | 372,909 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COMM | 604749101 | $7.9K | 454,974 | 0.0% |
| ChemoCentryx Inc(CCXIEUR) | COMM | 16383L106 | $7.0K | 113,213 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COMM | 481116101 | $6.5K | 925,280 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COMM | 74587V107 | $6.5K | 629,650 | 0.0% |
| Eli Lilly and Co(LLY) | COMM | 532457108 | $6.2K | 36,909 | 0.0% |
| Amarin Corp | ADR | 023111206 | $5.7K | 1,170,584 | 0.0% |
| Aligos Therapeutics Inc | COMM | 01626L105 | $5.3K | 191,061 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COMM | 00434H108 | $4.7K | 36,688 | 0.0% |